{"id":"https://openalex.org/A5035707014","orcid":"https://orcid.org/0009-0006-2443-1624","observed_orcids":["https://orcid.org/0009-0006-2443-1624"],"display_name":"Chinmay G. Shukla","raw_author_names":["C. Shukla","Chinmay G. Shukla","Chinmay Shukla"],"full_name":"Chinmay G. Shukla","works_count":20,"cited_by_count":325,"summary_stats":{"2yr_mean_citedness":1.1428571428571428,"h_index":9,"i10_index":8},"ids":{"openalex":"https://openalex.org/A5035707014","orcid":"https://orcid.org/0009-0006-2443-1624","observed_orcids":["https://orcid.org/0009-0006-2443-1624"]},"affiliations":[{"institution":{"id":"https://openalex.org/I1320320070","ror":"https://ror.org/034xvzb47","display_name":"United States Food and Drug Administration","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},"years":[2026,2025,2024,2022,2016,2014,2012]},{"institution":{"id":"https://openalex.org/I1333606569","ror":"https://ror.org/00yf3tm42","display_name":"Center for Drug Evaluation and Research","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},"years":[2026,2025,2024,2022,2016,2014,2012]},{"institution":{"id":"https://openalex.org/I138873065","ror":"https://ror.org/0324fzh77","display_name":"Long Island University","country_code":"US","type":"education","lineage":["https://openalex.org/I138873065"]},"years":[2011,2010,2009,2008,2003]},{"institution":{"id":"https://openalex.org/I4210136306","ror":"https://ror.org/0394gjn55","display_name":"BridgeBio (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136306"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I1320320070","ror":"https://ror.org/034xvzb47","display_name":"United States Food and Drug Administration","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","ror":"https://ror.org/00yf3tm42","display_name":"Center for Drug Evaluation and Research","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"id":"https://openalex.org/I4210136306","ror":"https://ror.org/0394gjn55","display_name":"BridgeBio (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136306"]}],"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","count":11,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","count":7,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","count":7,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":4,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":4,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","value":7.64e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","value":3.61e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":3.43e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14293","display_name":"Biotechnology and Related Fields","value":3.4e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","value":1.83e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","score":0.8886545896530151},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.6933780908584595},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.6660977005958557},{"id":"41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","score":0.41415220499038696},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.1679050624370575}],"counts_by_year":[{"year":2003,"works_count":1,"oa_works_count":0,"cited_by_count":46},{"year":2008,"works_count":1,"oa_works_count":0,"cited_by_count":25},{"year":2009,"works_count":2,"oa_works_count":0,"cited_by_count":27},{"year":2010,"works_count":1,"oa_works_count":0,"cited_by_count":6},{"year":2011,"works_count":1,"oa_works_count":0,"cited_by_count":9},{"year":2012,"works_count":1,"oa_works_count":0,"cited_by_count":3},{"year":2014,"works_count":4,"oa_works_count":2,"cited_by_count":134},{"year":2016,"works_count":1,"oa_works_count":0,"cited_by_count":27},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":40},{"year":2024,"works_count":2,"oa_works_count":0,"cited_by_count":7},{"year":2025,"works_count":2,"oa_works_count":1,"cited_by_count":1},{"year":2026,"works_count":3,"oa_works_count":3,"cited_by_count":0}],"display_name_alternatives":["C. Shukla","Chinmay G. Shukla","Chinmay Shukla"],"block_key":"c shukla","works_api_url":"https://api.openalex.org/works?filter=author.id:A5035707014","updated_date":"2026-10-12T12:34:37","created_date":"2022-09-06T00:00:00"}